REGENXBIO Inc. IPO Info

Company Name: REGENXBIO Inc.
Stock Symbol: RGNX
Exchange: NASDAQ
Status: Priced
IPO Date: 9/17/2015
IPO Price: 22.00 (-24.55%)

Underwriters

Morgan Stanley, BofA/Merrill Lynch, Piper Jaffray & Co., Chardan Capital Markets

Amount of Offering: 100,000,000
Number of Shares Offered: 5.6 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A

Company Description

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy.

SEC Filings

News Headlines

• REGENXBIO (RGNX) IPO Opens Up 38%
• REGENXBIO (RGNX) IPO Prices In-Line at $22
• REGENXBIO (RGNX) Sees IPO Price of $17 - $19/Share
• REGENXBIO (RGNX) Files for $100M Common Stock IPO